Careverse CoronaryDoc (Careverse CoronaryDoc)

by Careverse Technology Pte. Ltd.  · Based in Singapore → — Empower a new era of smart healthcare by creating an AI-powered Digital Doctor assisting human doctors to deliver much more efficient, accurate, consistent and accessible patient care.
Cardiology Radiology

Regulatory Status Disclosed

Overview

Careverse CoronaryDoc is an AI-powered coronary CTA analysis tool designed to automatically identify coronary arteries, detect stenosis, and characterize plaques. It delivers fast, accurate, and reproducible results, supporting clinical decision-making, enhancing workflow efficiency, and enabling early intervention in coronary artery disease across cardiology and radiology departments. The AI-driven algorithms for 3D reconstruction and segmentation allow clinicians to complete the post-processing workflow with minimal manual intervention in just three minutes. This facilitates the visualization and analysis of coronary CT angiography images, enabling precise assessment of coronary artery stenosis in patients with coronary artery disease, as well as accurate identification of atherosclerotic plaques, stents, and myocardial bridges. For precise diagnosis, Careverse CoronaryDoc revolutionizes the traditional radiology workflow by enabling fully automated vessel segmentation and image reconstruction, eliminating time-consuming post-processing and multi-step handoffs, with the entire process completed in as little as one minute.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered coronary CTA analysis
  • Automatic identification of coronary arteries
  • Detection of stenosis with over 90% accuracy
  • Characterization of plaques
  • Fast, accurate, and reproducible results
  • 3D reconstruction and segmentation of coronary arteries
  • Minimal manual intervention for post-processing
  • Fully automated vessel segmentation and image reconstruction
  • Handles complex clinical scenarios including bypasses, stents, myocardial bridges, and ectopic origins
  • Integration with CT-FFR for functional analysis of coronary arteries

Use Cases

  • Supporting clinical decision-making in cardiology and radiology departments
  • Enhancing workflow efficiency in medical imaging
  • Enabling early intervention in coronary artery disease
  • Precise assessment of coronary artery stenosis
  • Accurate identification of atherosclerotic plaques, stents, and myocardial bridges
  • Assisting in generating diagnostic suggestions and pre-reports

What Physicians Need to Know

Cardiac CT/MRI Analysis
Careverse CoronaryDoc is an AI-powered tool specifically designed for analyzing coronary CT examinations. It uses deep learning to extract the myocardium, blood vessels, stents, and plaques, streamlining the process of creating 3D and CPR images from CT scan data. The software also supports intelligent analysis of coronary vulnerable plaques, peri-coronary fat, and CT heart function, as well as coronary MRA AI and CMR AI products in MR modality. It can reconstruct complex cases, including those with bypasses, stents, myocardial bridges, and ectopic origins.
Coronary Artery Assessment
The tool automatically identifies coronary arteries, detects stenosis, and characterizes plaques. It offers fully automated vessel segmentation and image reconstruction, reducing post-processing time. Careverse CoronaryDoc can perform functional analysis using its CT-FFR product, providing an objective and convenient tool for assessing coronary artery stenosis. It also includes features for 3D reconstruction and naming of coronary arteries, 360° vessel lumen curved planar view, AI-based stent detection, and AI-based non-calcified plaque detection.
Arrhythmia Detection Accuracy
The system boasts a stenosis detection sensitivity of 93% and specificity of 90.9%. Multi-center validation has shown a 95% sensitivity in stenosis detection. It can automatically detect stenosis with an accuracy exceeding 90%.
Heart Failure Risk Prediction
Careverse's "Digital Heart" product family, which includes CoronaryDoc, aims to provide AI support for the diagnosis and treatment of cardiovascular disease patients at different stages. While not explicitly stated for CoronaryDoc, Careverse as a whole is involved in AI solutions that can predict the risk of heart failure.
Real-Time Alert Capability
Careverse's AI solutions, including those for coronary CTA, CT-FFR, pulmonary embolism, and aortic dissection diagnosis, act as a "Co-pilot" for radiologists, enhancing efficiency and enabling faster, more accurate diagnoses in emergency scenarios. The fully automated coronary CAD-RADs and CT-FFR analysis can be completed from image post-processing to reporting in just 3 minutes.
Physician Tip

Careverse CoronaryDoc significantly reduces the manual workload for radiologists by automating image post-processing and analysis, allowing more time for accurate diagnoses and collaboration. The tool provides rapid and accurate assessments, with a workflow from scan to report in as little as 3 minutes, which is particularly beneficial in acute chest pain cases. While the AI provides robust diagnostic support, physicians should always verify the product's extraction results and not use it as the sole evidence for clinical decision-making. The ability to perform both morphological and functional analysis (with CT-FFR) offers a comprehensive view for diagnosing coronary artery disease.

Careverse is actively seeking integration partners and offers various integration opportunities, including APIs, specialist tools, and AI agents. The company emphasizes connecting with clinical systems, and its solutions are designed to integrate into existing clinical workflows. Careverse's products cover various modalities like CT, MRI, ultrasound, X-rays, and mammography, suggesting a broad integration capability across different imaging platforms. The company has a public API program for eligible users and welcomes collaborations with AI companies, academic institutions, and technology platforms.

Details

Category Cardiology AI, Radiology & Imaging AI
Pricing Unknown
DeploymentLocalized deployment within the hospital intranet, keeps data privacy within a hospital.
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Cardiology, Radiology

What the Web Says

Careverse CoronaryDoc is an AI-powered tool designed for analyzing coronary CTA scans, aiming to enhance the diagnosis and treatment of coronary artery disease. It automatically identifies coronary arteries, detects stenosis, and characterizes plaques, providing fast, accurate, and reproducible results to support clinical decision-making. The software is intended to improve workflow efficiency and enable early intervention in cardiology and radiology departments.

Overall: Positive

Strengths

  • AI-powered for automatic identification of coronary arteries, stenosis detection, and plaque characterization.
  • Delivers fast, accurate, and reproducible results.
  • Supports clinical decision-making and enhances workflow efficiency.
  • Enables early intervention in coronary artery disease.
  • AI-driven algorithms allow for post-processing workflow completion in just three minutes with minimal manual intervention.
  • Facilitates precise assessment of coronary artery stenosis and accurate identification of atherosclerotic plaques, stents, and myocardial bridges.

Limitations

No significant limitations found in public reviews. Consider checking vendor documentation or requesting a demo for a thorough evaluation.

Based on reviews from: healthcareaiops.com, fda.gov, kln.com, irudigi.com, careverse.com

Last updated: 2026-10-29

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Careverse CoronaryDoc (Careverse CoronaryDoc)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

fda.gov
Careverse CoronaryDoc (Careverse CoronaryDoc)
Careverse CoronaryDoc received FDA 510(k) clearance on September 4, 2025, under product code QIH.
2025-09
careverse.com
Careverse Unveils “Digital Doctor” at ECR 2025, Paving the Way for the Future of Smart Healthcare
Careverse presented its AI-driven medical solutions, including Careverse CoronaryDoc, at ECR 2025, where it also announced a research collaboration with Diagnostikum. The Digital Heart suite, featuring Careverse CoronaryDoc and Careverse FFR, offers automated coronary CAD-RADs and CT-FFR analysis in three minutes.
2025-03
prnewswire.com
RSNA 2024 Spotlight: Careverse Leads the New Trend in Medical AI
Careverse debuted at RSNA 2024, showcasing its multimodal imaging AI and large language models, including its Coronary CTA product for cardiovascular disease. The Coronary CTA product aims to revolutionize radiology workflow by enabling fully automated vessel segmentation and image reconstruction, reducing post-processing time and improving efficiency.
2024-12
clairvotech.com
Shukun Technology (Careverse) Heart CT image analysis software Careverse CoronaryDoc released
Clairvo Technologies Inc. began domestic sales of Shukun Technology Co., Ltd.'s 'Careverse CoronaryDoc' heart CT image analysis software on October 15, 2024. This software utilizes AI to automate the reconstruction and analysis of cardiac CT images, aiming to reduce the burden on medical professionals.
2024-10
unitedwebnetwork.com
Careverse CoronaryDoc
Careverse CoronaryDoc is an AI-powered diagnostic support software for coronary artery disease that streamlines the workflow from scan to report, reducing post-processing and stenosis detection time from 30 minutes to 3 minutes. It has demonstrated 95% sensitivity in stenosis detection through multi-center validation.
unknown
irudigi.com
Careverse CoronaryDoc
Careverse CoronaryDoc uses AI-driven algorithms for 3D reconstruction and segmentation to complete the post-processing workflow in three minutes, enabling precise assessment of coronary artery stenosis and identification of plaques, stents, and myocardial bridges.
unknown
innolitics.com
Comprehensive analysis of 2025 cardiology AI/ML clearances, market trends, capital events, and regulatory insights
Careverse CoronaryDoc was among the 92 AI/ML-related FDA clearances in 2025, specifically noted in the coronary CT category for plaque-related tools.
2026-01
researchgate.net
The software “skCT-FFR”, marketed in Europe as “Careverse CoronaryDoc” and “Careverse FFR”, allows interactive user correction of the results
The software "skCT-FFR", marketed in Europe as "Careverse CoronaryDoc" and "Careverse FFR", allows interactive user correction of the results. This AI-based CT-FFR is a noninvasive tool that provides quick and reliable results, reducing unnecessary invasive testing and lowering healthcare costs.
2026-08

Videos

Product demos, reviews, and walkthroughs for Careverse CoronaryDoc (Careverse CoronaryDoc).

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

Careverse CoronaryDoc is designed to streamline the coronary CTA analysis workflow, from scan to report, reducing post-processing and stenosis detection time significantly. It helps in the recognition and display of coronary artery stenosis, plaque, stents, and myocardial bridges, assisting in diagnosing the degree of stenosis in patients with coronary heart disease. It is intended for use by trained physicians to support clinical decision-making, not as the sole evidence.
Careverse CoronaryDoc has received several regulatory approvals, including MDR CE certification and FDA 510(k) clearance. Careverse, as a company, adheres to personal data protection laws and policies in regions like the European Union and the United States.
Careverse CoronaryDoc should not be used as the sole evidence for clinical decision-making. It has contraindications for patients unsuitable for inclusion, those with incomplete coronary artery scanning ranges, or poor coronary CTA image quality due to severe artifacts like motion, calcification, or insufficient contrast.
Careverse CoronaryDoc offers a streamlined, AI-powered workflow that reduces coronary CTA post-processing and stenosis detection time from approximately 30 minutes to 3 minutes, demonstrating a 95% sensitivity in stenosis detection. Traditional diagnostic procedures for Coronary Artery Disease (CAD), such as CT angiography, can be invasive, costly, and physicians correctly diagnose CAD in only about 68% of cases.
The specific pricing model for Careverse CoronaryDoc is not publicly available. However, some users of CT-FFR software, which includes Careverse, have judged it to be cost-effective for CAD evaluation despite technical limitations.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-17 | First Added: 2026-04-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.